Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00805948 · ClinicalTrials.gov registry record · NA
Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)
A NA study, sponsored by Medtronic Cardiovascular.
- Terminated
- Registry status
- NA
- Development phase
- 349
- Enrollment target
NCT00805948 is a NA study that was terminated before completion, run by Medtronic Cardiovascular. The registered enrollment target is 349 participants.
The verdict
NCT00805948, a NA study, was terminated before completion, sponsored by Medtronic Cardiovascular.
- TERMINATED
- Registry status
- NA
- Development phase
- 349 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term safety and effectiveness of the Talent Thoracic Stent Graft System for treatment of descending thoracic aneurysms (DTA)following U.S. market approval.
Interventions
- DEVICE Talent Thoracic Stent Graft System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 349 participants |
| Start Date | 2009-04 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00805948
The ClinicalTrials.gov registry entry for NCT00805948 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 349 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Talent Thoracic Stent Graft System is the first listed.
NCT00805948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00805948 about?
NCT00805948 is a clinical study titled "Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)". The purpose of this study is to evaluate the long-term safety and effectiveness of the Talent Thoracic Stent Graft System for treatment of descending thoracic aneurysms (DTA)following U.S. market approval.
What is the current status of trial NCT00805948?
This trial is currently terminated. It is a NA study. The enrollment target is 349 participants. The study started on 2009-04. Estimated completion is 2017-08.
What interventions are being tested in trial NCT00805948?
The interventions under investigation include: Talent Thoracic Stent Graft System (DEVICE).
Who is sponsoring clinical trial NCT00805948?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.